Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
Marie Boyle, Steven Masson, Quentin M. Anstee
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 251-267
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam, Philip N. Newsome, Shiv Kumar Sarin, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 1, pp. 202-209
Open Access | Times Cited: 3207
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal, Jacob George, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1999-2014.e1
Open Access | Times Cited: 2561
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1138
Alcoholic liver disease
Helmut K. Seitz, Ramón Bataller, Helena Cortez‐Pinto, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 886
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin, Jiaofeng Huang, Ming-Fang Wang, et al.
Liver International (2020) Vol. 40, Iss. 9, pp. 2082-2089
Closed Access | Times Cited: 476
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 193
Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD
Mary E. Rinella, Frank Tacke, Arun J. Sanyal, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 4, pp. 823-833
Closed Access | Times Cited: 182
Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
Vy H. Nguyen, Michael H. Le, Ramsey Cheung, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 19, Iss. 10, pp. 2172-2181.e6
Closed Access | Times Cited: 172
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease
Fredrik Åberg, Christopher D. Byrne, Carlos J. Pirola, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 191-206
Open Access | Times Cited: 148
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
Gong Feng, Luca Valenti, Vincent Wai‐Sun Wong, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 1, pp. 46-56
Closed Access | Times Cited: 93
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Yao Yu, Jingjing Cai, Zhi‐Gang She, et al.
Advanced Science (2018) Vol. 6, Iss. 4
Open Access | Times Cited: 149
Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?
Shaheen Tomah, Naim Alkhouri, Osama Hamdy
Clinical Diabetes and Endocrinology (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 97
Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches
Óscar Soto-Angona, Gerard Anmella, María José Valdés-Florido, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 93
Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD
Mary E. Rinella, Frank Tacke, Arun J. Sanyal, et al.
Hepatology (2019) Vol. 70, Iss. 4, pp. 1424-1436
Closed Access | Times Cited: 88
Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches
Paola Dongiovanni, Erika Paolini, Alberto Corsini, et al.
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 7
Open Access | Times Cited: 56
Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score
Fredrik Åberg, Panu K. Luukkonen, Anna But, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 302-311
Open Access | Times Cited: 48
Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis
Helen Jarvis, Hannah O’Keefe, Dawn Craig, et al.
BMJ Open (2022) Vol. 12, Iss. 1, pp. e049767-e049767
Open Access | Times Cited: 41
Current Medical Treatment for Alcohol-Associated Liver Disease
Gustavo Ayares, Francisco Idalsoaga, Luis Antonio Díaz, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 12, Iss. 5, pp. 1333-1348
Open Access | Times Cited: 38
Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis
Mrigya Babuta, Caroline Morel, Marcelle de Carvalho Ribeiro, et al.
Gut (2024) Vol. 73, Iss. 11, pp. 1854-1869
Open Access | Times Cited: 10
Liver cancer risk across metabolic dysfunction-associated steatotic liver disease and/or alcohol: a nationwide study
Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 8
New Insights into the Pathogenesis of Alcoholic Liver Disease Based on Global Research
Jinbao Zhang, Zonghui Yang, Xiaona Liu, et al.
Digestive Diseases and Sciences (2025)
Closed Access | Times Cited: 1
The degree of hepatic steatosis associates with impaired cardiac and autonomic function
David Houghton, Paweł Zalewski, Kate Hallsworth, et al.
Journal of Hepatology (2019) Vol. 70, Iss. 6, pp. 1203-1213
Open Access | Times Cited: 68
Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis
Mads Israelsen, Helene Bæk Juel, Sönke Detlefsen, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 20, Iss. 8, pp. 1784-1794.e9
Open Access | Times Cited: 66
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions
Fredrik Åberg, Martti Färkkilâ
Seminars in Liver Disease (2020) Vol. 40, Iss. 02, pp. 154-162
Open Access | Times Cited: 60
A Designer Synbiotic Attenuates Chronic-Binge Ethanol-Induced Gut-Liver Injury in Mice
Sanjoy Roychowdhury, Bryan Glueck, Yingchun Han, et al.
Nutrients (2019) Vol. 11, Iss. 1, pp. 97-97
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top